~~<i id='B8C2FF07D0'><strike id='B8C2FF07D0'><tt id='B8C2FF07D0'><pre id='B8C2FF07D0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：comprehensive 2025-09-01 15:16:09 - browse：832

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Grail faces three suits alleging harassment, retaliation

hotspot

Wikipedia

focus

entertainment

KenaBetancur/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbi

WSS

Woman gored by Bison at Yellowstone

Does aspartame cause cancer? What new WHO guidance says

Anthos stroke drug appears safer than common blood thinner

Georgia court denies Trump's request to quash DA's 2020 election probe

Does good food count as health care? Study aims to find out

Congress: Eradicate hepatitis C and reduce the deficit

Wikipedia

knowledge

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Does aspartame cause cancer? What new WHO guidance says

DIEP, the 'gold standard' of breast reconstruction, is under threat

Weight loss drug costs may need more research, senator suggests

Medical leaders decry Supreme Court decision on affirmative action

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Psychedelics group wrestles with new pharma identity

Ransomware attacks on hospitals: Study outlines patient impact

After affirmative action ruling, medical educators look to 'holistic review'

Federal judge rules Oregon’s tough new gun law is constitutional

Wikipedia

Gain of function research would be limited under House proposal

Care demand spikes challenge UnitedHealth’s provider arm

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Blood tests recalled over risk of missed heart attack diagnosis

Morphosys mixed study results for blood cancer drug

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Wikipedia

focus

entertainment

entertainment